Related Experiment Video
Updated: Apr 30, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Cardiac steatosis in patients with dilated cardiomyopathy
Marit Granér1, Markku O Pentikäinen1, Kristofer Nyman2
1Division of Cardiology, Diabetes and Obesity Research Program, Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Insights
In patients with dilated cardiomyopathy (DCM), myocardial fat (triglyceride) content was lower, while epicardial and pericardial fat were higher. This suggests a specific role for fat metabolism in heart failure.
Area of Science:
- Cardiology
- Metabolic Research
- Medical Imaging
Background:
- Ectopic fat accumulation, particularly cardiac steatosis, is linked to increased cardiovascular disease risk.
- Limited data exists on cardiac adiposity in patients diagnosed with dilated cardiomyopathy (DCM).
Purpose of the Study:
- To investigate the components of cardiac steatosis in non-diabetic DCM patients.
- To explore the relationship between cardiac fat depots and left ventricular (LV) structure and function.
Main Methods:
- Utilized 1.5 Tesla magnetic resonance spectroscopy (MRS) to measure myocardial and hepatic triglyceride (TG) content.
- Employed MRI to assess LV function, visceral adipose tissue (VAT), abdominal subcutaneous tissue (SAT), and epicardial and pericardial fat.
- Compared 10 non-diabetic men with DCM against 20 healthy controls.
Main Results:
- Patients with DCM exhibited significantly lower myocardial TG content compared to controls (0.41% vs. 0.86%).
- Epicardial (895 mm² vs. 664 mm²) and pericardial fat depots were significantly larger in DCM patients.
- LV global function index was more severely reduced in DCM patients than LV ejection fraction (EF).
Conclusions:
- Non-diabetic DCM subjects showed decreased myocardial TG and increased epicardial/pericardial fat.
- Altered myocardial TG content appears to play a specific role in myocardial energy metabolism within the context of congestive heart failure.
Objective:
Ectopic fat accumulation within and around the heart has been related to increased risk of heart disease. Limited data exist on cardiac adiposity in subjects with dilated cardiomyopathy (DCM). The aim of the study was to examine the components of cardiac steatosis and their relationship to LV structure and function in non-diabetic DCM patients.
Methods:
Myocardial and hepatic triglyceride (TG) contents were measured with 1.5 T magnetic resonance spectroscopy (MRS), and LV function, visceral adipose (VAT) and abdominal subcutaneous tissue (SAT), epicardial and pericardial fat by MRI in 10 non-diabetic men with DCM and in 20 controls.
Results:
In face of comparable intra-abdominal fat depots, myocardial TG [0.41% (0.21-2.19) vs. 0.86% (0.31-2.24), p=0.038] was markedly lower and epicardial (895 mm2±110 vs. 664 mm2±180, p=0.002) and pericardial fat [2173 mm2 (616-3673) vs 1168 mm2 (266-2319), p=0.039] depots were larger in patients with DCM compared with controls. In subjects with DCM, the LV global function index was decreased to a greater extent than the LV EF [21%±6 vs. 34% (16-40)].
Conclusions:
Myocardial TG content decreased and epicardial and pericardial fat depots increased in non-diabetic subjects with DCM. Although recognised as a site of ectopic fat accumulation, the derangement of myocardial TG seems to play a specific role in the myocardial energy metabolism in congestive heart failure.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

